Table A5.
Item | Value | S.E. | Source |
---|---|---|---|
Proportion of brexu-cel patients who visit ICU | 22.7% | ZUMA-2 Clinical Study Report [38] | |
% of BSC patients who visit ICU | 0 | 0 | ~ |
Average duration in ICU | 21.2 days | 1.80 | ZUMA-2 Clinical Study report [38] |
Total hospitalization cost | CAD 63,758.81 | 0 | ~ |
Abbreviation: BSC, best supportive care.